Eventide Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Eventide Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.79K	Buy	+94	New	+$2.67K	﹤0.01%	301
2021 Q1	–	Sell	-112,000	Closed	-$11.1M	–	167
2020 Q4	$11.1M	Buy	112,000 +61,000	+120%	+$7.46M	0.17%	106
2020 Q3	$7.24M	Hold	51,000	–	–	0.14%	107
2020 Q2	$10.1M	Hold	51,000	–	–	0.22%	95
2020 Q1	$9.99M	Hold	51,000	–	–	0.32%	85
2019 Q4	$10.5M	Sell	51,000 -122,000	-71%	-$22.6M	0.3%	77
2019 Q3	$26.4M	Hold	173,000	–	–	0.87%	42
2019 Q2	$22.3M	Hold	173,000	–	–	0.68%	55
2019 Q1	$20.4M	Buy	173,000 +133,000	+333%	+$13.4M	0.7%	55
2018 Q4	$3.67M	Hold	40,000	–	–	0.16%	93
2018 Q3	$4.5M	Hold	40,000	–	–	0.17%	101
2018 Q2	$3.69M	Hold	40,000	–	–	0.15%	97
2018 Q1	$3.99M	Sell	40,000 -12,000	-23%	-$1.29M	0.19%	92
2017 Q4	$4.88M	Hold	52,000	–	–	0.25%	85
2017 Q3	$5.29M	Hold	52,000	–	–	0.3%	74
2017 Q2	$3.98M	Hold	52,000	–	–	0.25%	78
2017 Q1	$4.48M	Hold	52,000	–	–	0.3%	75
2016 Q4	$3.34M	Hold	52,000	–	–	0.22%	83
2016 Q3	$3.36M	Hold	52,000	–	–	0.21%	82
2016 Q2	$2.88M	Hold	52,000	–	–	0.18%	86
2016 Q1	$2.17M	Buy	+52,000	New	+$2.41M	0.12%	99

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Eventide Asset Management's LKFT Position: Q2 2026 in Review

Eventide Asset Management opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026: 94 shares worth $2.79K. The stake represents ﹤0.01% of the portfolio and ranks #301 among its holdings. This is a return to the name: Eventide Asset Management previously reported a position in LKFT as recently as Q4 2020.

Eventide Asset Management first reported a position in LKFT in Q1 2016 and has held it in 21 quarters since. The position peaked at $26.4M in Q3 2019. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

Eventide Asset Management held 94 shares of Lakefront Biotherapeutics American Depositary Shares worth $2.79K as of Q2 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Eventide Asset Management position in Q2 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Eventide Asset Management's portfolio in Q2 2026, its #301 holding.
Eventide Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2016 and has held it in 21 quarters since.
Eventide Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $26.4M in Q3 2019.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.